IA
SIOX

IPL Advisers’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

IPL Advisers’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$6.37M Hold
150,995
– – 4.03% 11
2017
Q3 		$8.31M Buy
150,995
+54,627
+57% +$9.22M 3.4% 13
2017
Q2 		$17.9M Sell
96,368
-23,629
-20% -$4.14M 7.06% 9
2017
Q1 		$14.3M Hold
119,997
– – 6.17% 8
2016
Q4 		$11.9M Buy
+119,997
New +$12.6M 3.31% 12

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IPLA
Ice Pond Lane Advisers New York $7.38M AUM 1.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IPL Advisers's SIOX Position: Q4 2017 in Review

IPL Advisers held its Sio Gene Therapies Inc. Common Stock (SIOX) position steady in Q4 2017 at 150,995 shares worth $6.37M. The position accounts for 4.03% of the portfolio, ranked #11.

IPL Advisers first reported a position in SIOX in Q4 2016 and has held it in 5 quarters since. The position peaked at $17.9M in Q2 2017. 104 funds tracked by Wall St. Rank hold SIOX as of Q4 2017.

  • IPL Advisers held 150,995 shares of Sio Gene Therapies Inc. Common Stock worth $6.37M as of Q4 2017.
  • IPL Advisers left its Sio Gene Therapies Inc. Common Stock share count unchanged in Q4 2017.
  • Sio Gene Therapies Inc. Common Stock made up 4.03% of IPL Advisers's portfolio in Q4 2017, its #11 holding.
  • IPL Advisers first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2016 and has held it in 5 quarters since.
  • IPL Advisers's Sio Gene Therapies Inc. Common Stock position peaked at $17.9M in Q2 2017.
  • 104 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2017.

Based on IPL Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.